Hsueh-Yun Lee - Search Results

Year	Number of Results
2009	1
2011	5
2012	3
2013	3
2014	9
2015	5
2016	6
2017	4
2018	6
2019	5
2020	3
2021	5
2022	3
2023	7
2024	0

1

Nepali K, Lee HY, Liou JP. Nepali K, et al. Among authors: lee hy. J Med Chem. 2019 Mar 28;62(6):2851-2893. doi: 10.1021/acs.jmedchem.8b00147. Epub 2018 Nov 1. J Med Chem. 2019. PMID: 30295477

2

Tubulin inhibitors: a patent review.

Liu YM, Chen HL, Lee HY, Liou JP. Liu YM, et al. Among authors: lee hy. Expert Opin Ther Pat. 2014 Jan;24(1):69-88. doi: 10.1517/13543776.2014.859247. Epub 2013 Dec 9. Expert Opin Ther Pat. 2014. PMID: 24313741 Review.

3

In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer.

Chang CD, Chao MW, Lee HY, Liu YT, Tu HJ, Lien ST, Lin TE, Sung TY, Yen SC, Huang SH, Hsu KC, Pan SL. Chang CD, et al. Among authors: lee hy. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2166039. doi: 10.1080/14756366.2023.2166039. J Enzyme Inhib Med Chem. 2023. PMID: 36683274 Free PMC article.

4

Synthesis and biological evaluation of 2-quinolineacrylamides.

Wang SW, Lin MH, Hsu FC, Chen MC, Liou JP, Liu YT, Chen SS, Lee HY. Wang SW, et al. Among authors: lee hy. Bioorg Med Chem. 2020 Feb 1;28(3):115250. doi: 10.1016/j.bmc.2019.115250. Epub 2019 Dec 19. Bioorg Med Chem. 2020. PMID: 31924504

5

Early investigational tubulin inhibitors as novel cancer therapeutics.

Nepali K, Ojha R, Lee HY, Liou JP. Nepali K, et al. Among authors: lee hy. Expert Opin Investig Drugs. 2016 Aug;25(8):917-36. doi: 10.1080/13543784.2016.1189901. Epub 2016 May 30. Expert Opin Investig Drugs. 2016. PMID: 27186892 Review.

6

Total Synthesis of Denbinobin.

Lee HY, Kumar S, Lin TC, Liou JP. Lee HY, et al. J Nat Prod. 2016 Apr 22;79(4):1170-3. doi: 10.1021/acs.jnatprod.5b00959. Epub 2016 Mar 24. J Nat Prod. 2016. PMID: 27010570

7

Definition of fatty acid transport protein-2 (FATP2) structure facilitates identification of small molecule inhibitors for the treatment of diabetic complications.

Kumar M, Gaivin RJ, Khan S, Fedorov Y, Adams DJ, Zhao W, Lee HY, Dai X, Dealwis CG, Schelling JR. Kumar M, et al. Among authors: lee hy. Int J Biol Macromol. 2023 Jul 31;244:125328. doi: 10.1016/j.ijbiomac.2023.125328. Epub 2023 Jun 10. Int J Biol Macromol. 2023. PMID: 37307967

8

CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents.

Peng CM, Wang SW, Hwang YL, Sun WC, Chiu LP, Liu YT, Lai YW, Lee HY. Peng CM, et al. Among authors: lee hy. RSC Adv. 2023 Apr 28;13(19):13169-13176. doi: 10.1039/d3ra01927f. eCollection 2023 Apr 24. RSC Adv. 2023. PMID: 37124006 Free PMC article.

9

Structure-guided design of anti-cancer ribonucleotide reductase inhibitors.

Misko TA, Liu YT, Harris ME, Oleinick NL, Pink J, Lee HY, Dealwis CG. Misko TA, et al. Among authors: lee hy. J Enzyme Inhib Med Chem. 2019 Dec;34(1):438-450. doi: 10.1080/14756366.2018.1545226. J Enzyme Inhib Med Chem. 2019. PMID: 30734609 Free PMC article.

10

6-Regioisomeric 5,8-quinolinediones as potent CDC25 inhibitors against colorectal cancers.

Narwanti I, Yu ZY, Sethy B, Lai MJ, Lee HY, Olena P, Lee SB, Liou JP. Narwanti I, et al. Among authors: lee hy. Eur J Med Chem. 2023 Oct 5;258:115505. doi: 10.1016/j.ejmech.2023.115505. Epub 2023 Jun 2. Eur J Med Chem. 2023. PMID: 37302341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

55 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year